Late-onset medullary carcinoma of the thyroid: Need for genetic testing and prophylactic thyroidectomy in adult family members

被引:15
作者
Shaha, Ashok R.
Cohen, Tzeela
Ghossein, Ronald
Tuttle, R. Michael
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Endocrine Serv, New York, NY 10021 USA
关键词
thyroid cancer; medullary thyroid cancer; RET proto-oncogene; C-cell hyperplasia;
D O I
10.1097/01.mlg.0000233509.83679.ee
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: Sporadic late-onset medullary carcinoma of the thyroid is quite rare. Usually, the patient presents with a thyroid mass or neck node metastasis along with high levels of calcitonin and preoperative fine needle aspiration biopsy suggestive of medullary carcinoma of the thyroid. The role of genetic testing in such individuals, along with testing of other family members, remains somewhat unclear at this stage, especially in patients presenting with familial medullary thyroid carcinoma. Genetic testing with RET proto-oncogene mutational studies is very popular in familial medullary thyroid carcinoma, especially in children, with routine prophylactic thyroidectomy. However, its indications in adults remain unclear at this time: Case Study: Recently, a 69-year-old woman presented with a thyroid mass and underwent total thyroidectomy and central compartment dissection. She was found to have medullary carcinoma of the thyroid. The patient had four children, three of whom were found to have a RET mutation similar to their mother's, V804M. In view of the RET mutation, the three children were offered prophylactic thyroidectomy at ages 42, 45, and 47. The patient's son was noted to have extensive C-cell hyperplasia in both lobes of the thyroid. The other two individuals had benign pathology with no evidence of C-cell hyperplasia. Conclusions: There is no definite consensus of opinion about the need for prophylactic total thyroidectomy in adults with RET mutation. The rarely reported 804 mutation is, however, a predictor of medullary carcinoma of the thyroid. One individual in this group had extensive C-cell hyperplasia, suggesting that he would have developed medullary carcinoma of the thyroid in the future. Prophylactic thyroidectomy should be recommended in patients with RET mutation and a family history of medullary carcinoma of the thyroid; however, its role in adult family members needs to be evaluated with larger registry of prophylactic thyroidectomy. Whether these adults with rare 804-mutation could be observed and followed with serial calcitonin, ultrasound, or calcitonin stimulation tests remains to be studied.
引用
收藏
页码:1704 / 1707
页数:4
相关论文
共 18 条
[1]   Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors [J].
Carlomagno, F ;
Guida, T ;
Anaganti, S ;
Vecchio, G ;
Fusco, A ;
Ryan, AJ ;
Billaud, M ;
Santoro, M .
ONCOGENE, 2004, 23 (36) :6056-6063
[2]   Medullary thyroid cancer [J].
Clayman, GL ;
El-Baradie, TS .
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2003, 36 (01) :91-+
[3]   Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma:: German and Austrian experience [J].
Dralle, H ;
Gimm, O ;
Simon, D ;
Frank-Raue, K ;
Görtz, G ;
Niederle, B ;
Wahl, RA ;
Koch, B ;
Walgenbach, S ;
Hampel, R ;
Ritter, MM ;
Spelsberg, F ;
Heiss, A ;
Hinze, R ;
Höppner, W .
WORLD JOURNAL OF SURGERY, 1998, 22 (07) :744-751
[4]   The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis [J].
Eng, C ;
Clayton, D ;
Schuffenecker, I ;
Lenoir, G ;
Cote, G ;
Gagel, RF ;
vanAmstel, HKP ;
Lips, CJM ;
Nishisho, I ;
Takai, SI ;
Marsh, DJ ;
Robinson, BG ;
FrankRaue, K ;
Raue, F ;
Xue, FY ;
Noll, WW ;
Romei, C ;
Pacini, F ;
Fink, M ;
Niederle, B ;
Zedenius, J ;
Nordenskjold, M ;
Komminoth, P ;
Hendy, GN ;
Gharib, H ;
Thibodeau, SN ;
Lacroix, A ;
Frilling, A ;
Ponder, BAJ ;
Mulligan, LM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19) :1575-1579
[5]   Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG→ATG) mutation [J].
Feldman, GL ;
Edmonds, MW ;
Ainsworth, PJ ;
Schuffenecker, I ;
Lenoir, GM ;
Saxe, AW ;
Talpos, GB ;
Roberson, J ;
Petrucelli, N ;
Jackson, CE .
SURGERY, 2000, 128 (01) :93-98
[6]   Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634 [J].
Gimm, O ;
Ukkat, J ;
Niederle, BE ;
Weber, T ;
Thanh, PN ;
Brauckhoff, M ;
Niederle, B ;
Dralle, H .
WORLD JOURNAL OF SURGERY, 2004, 28 (12) :1312-1316
[7]  
Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO
[8]  
2-1
[9]   Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma/multiple endocrine neoplasia type 2A patients [J].
Lesueur, F ;
Cebrian, A ;
Cranston, A ;
Leyland, J ;
Faid, TM ;
Clements, MR ;
Robledo, M ;
Whittaker, J ;
Ponder, BAJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06) :3454-3457
[10]   Familial medullary thyroid carcinoma:: Clinical variability and low aggressiveness associated with RET mutation at codon 804 [J].
Lombardo, F ;
Baudin, E ;
Chiefari, E ;
Arturi, F ;
Bardet, S ;
Caillou, B ;
Conte, C ;
Dallapiccola, B ;
Giuffrida, D ;
Bidart, JM ;
Schlumberger, M ;
Filetti, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1674-1680